Patrick A. Brown
Haemonetics (United States)(US)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Childhood Cancer Survivors' Quality of Life, CAR-T cell therapy research
Most-Cited Works
- → RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia(2011)1,858 cited
- → Treatment of Pediatric Acute Lymphoblastic Leukemia(2014)346 cited
- → Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia(2021)344 cited
- → The genomic landscape of juvenile myelomonocytic leukemia(2015)306 cited
- → Acute Lymphoblastic Leukemia, Version 2.2015(2015)244 cited
- → Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology(2021)234 cited
- → The incidence and clinical significance of nucleophosmin mutations in childhood AML(2007)218 cited
- → FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression(2004)213 cited
- → Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology(2020)208 cited
- → Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors(2006)203 cited